These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9701735)

  • 1. Electrovaporization of the prostate versus laser ablation of the prostate in men with benign prostatic hypertrophy: a pressure-flow analysis.
    Shingleton WB; Kolski J; Renfroe DL; Fowler JE
    Urol Int; 1998 Aug; 60(4):224-8. PubMed ID: 9701735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized prospective study of transurethral electrovaporization vs laser ablation of the prostate in men with benign prostatic hypertrophy.
    Shingleton WB; Renfroe LD; Kolski JM; Fowler JE
    Scand J Urol Nephrol; 1998 Jul; 32(4):266-9. PubMed ID: 9764453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transurethral electrovaporization of the prostate versus transurethral resection of the prostate: a prospective randomized study.
    Erdaği U; Akman RY; Sargin SY; Yazicioğlu A
    Arch Ital Urol Androl; 1999 Jun; 71(3):125-30. PubMed ID: 10431402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study.
    Roehrborn CG; Burkhard FC; Bruskewitz RC; Issa MM; Perez-Marrero R; Naslund MJ; Shumaker BP
    J Urol; 1999 Jul; 162(1):92-7. PubMed ID: 10379748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transurethral electrovaporization of the prostate vs. transurethral resection. Results of a multicentric, randomized clinical study on 150 patients.
    Gallucci M; Puppo P; Perachino M; Fortunato P; Muto G; Breda G; Mandressi A; Comeri G; Boccafoschi C; Francesca F; Guazzieri S; Pappagallo GL
    Eur Urol; 1998; 33(4):359-64. PubMed ID: 9612677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of vaportrode transurethral vaporization of the prostate using pressure-flow urodynamic criteria.
    Desautel MG; Burney TL; Diaz PA; Austria A; Badlani GH
    Urology; 1998 Jun; 51(6):1013-7. PubMed ID: 9609642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of benign prostatic hyperplasia by transurethral ultrasound-guided laser-induced prostatectomy (TULIP): effects on urodynamic parameters and symptoms.
    Bosch JL; Groen J; Schröder FH
    Urology; 1994 Oct; 44(4):507-11. PubMed ID: 7524235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).
    Tan AH; Gilling PJ; Kennett KM; Frampton C; Westenberg AM; Fraundorfer MR
    J Urol; 2003 Oct; 170(4 Pt 1):1270-4. PubMed ID: 14501739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
    Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
    BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of prostate size on the outcome of transurethral laser evaporation of the prostate for benign prostatic hyperplasia.
    Narayan P; Tewari A; Fournier G; Toke A
    Urology; 1995 May; 45(5):776-82. PubMed ID: 7538239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
    Hamann MF; Naumann CM; Seif C; van der Horst C; Jünemann KP; Braun PM
    Eur Urol; 2008 Oct; 54(4):902-7. PubMed ID: 18502565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transurethral electrovaporization of the prostate: a novel method for treating men with benign prostatic hyperplasia.
    Kaplan SA; Te AE
    Urology; 1995 Apr; 45(4):566-72. PubMed ID: 7536365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of transurethral electrovaporization of the prostate with respect to standard transurethral resection.
    Küpeli B; Yalçinkaya F; Topaloğlu H; Karabacak O; Günlüsoy B; Unal S
    J Endourol; 1998 Dec; 12(6):591-4. PubMed ID: 9895267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contact laser treatment for benign prostatic hypertrophy.
    Montanari E; Guarneri A; Pozzoni F; Gelosa M; Del Nero A; Trinchieri A; Zanetti G; Pisani E
    Arch Ital Urol Androl; 1999 Jun; 71(3):135-42. PubMed ID: 10431404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome at 3 months after transurethral vaporization of prostate for benign prostatic hyperplasia.
    Chen SS; Chiu AW; Lin AT; Chen KK; Chang LS
    Urology; 1997 Aug; 50(2):235-8. PubMed ID: 9255294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term efficacy of transurethral electrovaporization of the prostate for symptomatic benign prostatic hyperplasia].
    Shao Q; Lu W; Zhang Y
    Zhonghua Wai Ke Za Zhi; 1999 Jul; 37(7):440-2. PubMed ID: 11829885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised prospective trial of contact laser prostatectomy (CLAP) versus visual laser coagulation of the prostate (VLAP) for the treatment of benign prostatic hyperplasia. 2-year follow-up.
    Bryan NP; Hastie KJ; Chapple CR
    Eur Urol; 2000 Sep; 38(3):265-71. PubMed ID: 10940699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Holmium laser versus transurethral resection of the prostate: a randomized prospective trial with 1-year followup.
    Gilling PJ; Mackey M; Cresswell M; Kennett K; Kabalin JN; Fraundorfer MR
    J Urol; 1999 Nov; 162(5):1640-4. PubMed ID: 10524887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urodynamic effects of Prolase 2 laser prostatectomy in benign prostatic hyperplasia.
    Van Erps P; Schapmans S; Cortvriend J; D'Hont C; Denis LJ
    Acta Urol Belg; 1995 Sep; 63(3):39-43. PubMed ID: 7484521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.